Have US equities finally peaked relative to European equities?

Have US equities finally peaked relative to European equities?

Equities 7 minutes to read
Peter Garnry

Chief Investment Strategist

Summary:  In this equity note we highlight that US equities might soon be peaking against European equities on ground of relative total return performance, valuation differences and that European equities could benefit from an edge in green energy technologies and health care compared to the US. We also highlight the smaller technology sector weight as a potential catalyst for European equities over time.


US equities have shown an extraordinary rebound since March lows compared to European equities driven by strong price action in technology and biotechnology stocks. As we have said many times over the past weeks we guess that an enormous speculative retail flow in the US is behind most of the price action and thus pushing valuations to very high levels. The disconnect between fundamentals and sentiment has pushed US equities to an extreme outperformance relative to Europe that one has to ponder whether this can continue.

The relative total return indices in USD between US and European equities have moved to 3.4 standard deviations indicating that US equities have drifted significantly away from its long-term relationship to European equities. The last extreme US outperformance has happened since September 2017 where US equities are up 20% and European equities are down 14% in USD terms.

European equities reached its peak outperformance against US equities around the end of 2007 but since then the fortunes have changed. US equities are up 140% and European equities are down 4%  in USD terms. Two major events happened in the subsequent period. The trade-weighted real USD rose 28% adding tailwind for US assets relative to non-US assets and the technology sector went through a massive boom through search engines (online advertising), smartphones, social media, video streaming, cloud-based application software, cloud-based infrastructure, machine learning and its related chip infrastructure, e-commerce platforms and online shopping. The US had the upper hand in the recent technology boom with Silicon Valley financing technology ventures that managed to gain wide dominance before Europe’s fragmented technology hubs could come up with alternatives. Many of these emerging technologies had economics of scale that had not been seen since the 1960s industrial boom and the 1980s energy boom. European equity markets were basically living in the past. A final important driver was that US companies were in general net buyers of their own shares where European companies continued to be net issuer of equity capital.

The table above shows the changes in sector weights for S&P 500 and STOXX 600 since December 2007. While the collapse in the US energy sector has been significant it has been outweighed by the rise in technology (Microsoft and Apple), consumer discretionary (Amazon) and communications (Facebook and Alphabet). The biggest losing sector in Europe has been the financials which were dominant in 2007, but is still the largest sector, but has since lost its profitability as the Euro crisis and wrong policies have made it difficult to operate banks. Europe’s two biggest winners have been health care stocks and consumer staples and here lies some of the future potential.

What is the case for being positive and overweight European equities? Valuation is much better on European equities with a forward dividend yield of 2.8% and dividend futures expecting annualized dividend growth of 0.6% until 2023. On top of that the P/E multiple is lower on European equities relative to US equities so European equities could get a relative better P/E multiple over the coming years. US equities are currently priced with a forward dividend yield of 1.7% and dividend futures expecting negative 3.3% annualized dividend growth until 2023. This means that US equities need P/E multiple expansion much more than European equities to continue to deliver outperformance. That’s going to be difficult.

In the case economic activity is subdued globally the coming years European equities offer more defensive characteristics with a higher weight on consumer staples, health care and utilities. Europe is leading on the green transformation and here lies another upside through the industrials and utilities sectors. With only 7.5% of European equities in the technology sector there’s also room for a higher weight over time which will improve the growth profile of European equity markets. Finally with Europe’s large health care share and the increased focus on drug discovery and health care equipment after COVID-19 Europe does have an edge.

On the  macro side a weaker USD, which is urgently needed by many countries, would add tailwind for non-US equities. Europe’s potential fiscal integration with the EU Commission issuing joint debt has the potential to solve some of Europe’s structural issues which also could be a positive for European equities. Increasing technology regulation could also increase costs for US technology companies and thus act as a drag on US equities.

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992